PT
Pierrepont Therapeutics, Inc.
SEC filingPharmaceuticals · Brooklyn, NY
Amount raised$2.4Msold at filing
Total offering$5.9M$3.5M still open
Investors in the raise2count reported to the SEC
FiledSep 22, 2026first sale Apr 2, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Peter H. BarberExecutive Officer, Director
Matthew H. WyckoffDirector
Daniel H. DiPietroDirector
Executive officers, directors and promoters as listed on the Form D.